title: Comparative measurement of CNP and NT-proCNP in human blood samples: a methodological evaluation.
abstract: BACKGROUND
  C-type natriuretic peptide (CNP) has anti-inflammatory, anti-proliferative, and anti-migratory properties. During the past years, CNP has attained an increasing interest by many research groups, especially in the cardiovascular field. Nevertheless, still no reliable data exist on the difference of CNP concentration between serum and plasma samples. Also, the influence of delayed blood sample proceeding is unknown. The aim of this study was to investigate the difference of CNP and NT-proCNP concentrations between serum and plasma samples. In order to identify potential methodological bias, this study should also validate the stability of CNP and NT-proCNP in full blood samples stored at room temperature.
  
  
  RESULTS
  Triplets (serum, plasma, full blood) of fasting blood samples from 12 healthy male individuals were collected. Analysis of CNP and NT-proCNP concentration was performed immediately following sampling, and after 30 minutes or 2 hours of storage at room temperature. Mean serum concentrations at baseline were 0.997 ± 0.379 ng/ml for CNP and 58.5 ± 28.3 pg/ml for NT-proCNP. Furthermore, NT-proCNP concentration did not change significantly during the allotted time and did not differ between serum, plasma, and full blood samples. At baseline, concentrations of CNP were significantly different between samples containing either sodium-citrate or EDTA as a clotting inhibitor (1.933 ± 0.699 ng/ml vs. 0.991 ± 0.489 ng/ml, p = 0.001).
  
  
  CONCLUSIONS
  CNP and NT-proCNP are stable for at least two hours, even when sample processing is delayed or blood probes are stored at room temperature. NT-proCNP assay demonstrated more consistent and reliable data and should therefore be preferred for usage in clinical applications. Nevertheless, as recommended for ANP and BNP, immunoassays for CNP should also be standardized or harmonized in the future.
authors.affiliation: Clinic for Vascular and Endovascular Surgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
authors.forename: Andreas
authors.initials: A
authors.lastname: Kuehnl
authors.forename: Jaroslav
authors.initials: J
authors.lastname: Pelisek
authors.forename: Martin
authors.initials: M
authors.lastname: Bruckmeier
authors.forename: Wajima
authors.initials: W
authors.lastname: Safi
authors.forename: Hans-Henning
authors.initials: HH
authors.lastname: Eckstein
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D020098:Natriuretic Peptide, C-Type / Q000097:blood*; D012016:Reference Values
chemical_list: C480579:amino-terminal pro-C-type natriuretic peptide, human; D020098:Natriuretic Peptide, C-Type
references.citation: J Mol Med (Berl). 2007 Aug;85(8):797-810
references.pmid: 17429599
references.citation: Eur J Vasc Endovasc Surg. 2012 Jun;43(6):649-54
references.pmid: 22421372
references.citation: J Am Coll Cardiol. 2011 Mar 22;57(12):1396-8
references.pmid: 21414537
references.citation: Connect Tissue Res. 2010 Apr;51(2):83-7
references.pmid: 20001845
references.citation: Biochem Biophys Res Commun. 2001 Aug 24;286(3):513-7
references.pmid: 11511088
references.citation: Clin Chim Acta. 2012 Dec 24;414:112-9
references.pmid: 22910582
references.citation: J Histochem Cytochem. 2002 Jun;50(6):799-809
references.pmid: 12019296
references.citation: Peptides. 2007 May;28(5):1068-73
references.pmid: 17428580
references.citation: Clin Endocrinol (Oxf). 2012 Sep;77(3):416-22
references.pmid: 22435455
references.citation: Peptides. 2012 Jan;33(1):83-6
references.pmid: 22100730
references.citation: Eur Urol. 2009 Sep;56(3):552-8
references.pmid: 19038490
references.citation: Eur J Heart Fail. 2005 Dec;7(7):1145-8
references.pmid: 15922659
references.citation: Clin Chem. 2000 Oct;46(10):1529-34
references.pmid: 11017928
references.citation: Vasa. 2006 Nov;35(4):215-20
references.pmid: 17109362
references.citation: J Gene Med. 2006 Jul;8(7):835-44
references.pmid: 16602133
references.citation: Malar J. 2008 Dec 15;7:253
references.pmid: 19077312
references.citation: Clin Rheumatol. 2008 Sep;27(9):1153-8
references.pmid: 18414966
references.citation: Adv Clin Chem. 2012;58:31-44
references.pmid: 22950341
references.citation: Regul Pept. 2011 Jan 17;166(1-3):15-20
references.pmid: 20800621
references.citation: Hypertension. 2009 Sep;54(3):612-8
references.pmid: 19620509
references.citation: Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1646-51
references.pmid: 15231517
references.citation: Clin Chem. 2004 Jan;50(1):33-50
references.pmid: 14633912
references.citation: Peptides. 2005 Jun;26(6):1044-59
references.pmid: 15911072
references.citation: J Clin Endocrinol Metab. 2007 Nov;92(11):4294-8
references.pmid: 17684048
references.citation: J Endovasc Ther. 2005 Apr;12(2):171-82
references.pmid: 15823063
references.citation: Am J Physiol Lung Cell Mol Physiol. 2009 Feb;296(2):L248-56
references.pmid: 19036874
references.citation: Gut. 2000 Dec;47(6):852-7
references.pmid: 11076886
references.citation: Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):10079-84
references.pmid: 12893874